During the past decade, Canterbury Health Laboratories conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canterbury Health Laboratories" #1 sponsor was "Amgen" with 1 trials, followed by "BeiGene" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canterbury Health Laboratories" #1 collaborator was "British Medical Research Council" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator, "Lymphoma Trials Office" with 1 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Canterbury Health Laboratories" are "Leukemia" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Brain and Central Nervous System Tumors" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Cytomegalovirus (CMV)" (1 trials). Many other conditions were trialed in "Canterbury Health Laboratories" in a lesser frequency.

Most popular intervention types in "Canterbury Health Laboratories" are "Drug" (11 trials), "Biological" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials), "cyclophosphamide" (2 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canterbury Health Laboratories" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Canterbury Health Laboratories". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Canterbury Health Laboratories, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Canterbury Health Laboratories, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".